J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 559, Number 3, 849-862, September 15, 2004 DOI: 10.1113/jphysiol.2004.068676
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
559/3/849    most recent
jphysiol.2004.068676v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishimaru, K.
Right arrow Articles by Toro, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishimaru, K.
Right arrow Articles by Toro, L.

Functional and molecular evidence of MaxiK channel ß1 subunit decrease with coronary artery ageing in the rat

Kazuhide Nishimaru1, Mansoureh Eghbali1, Rong Lu1, Jure Marijic1, Enrico Stefani1,3,4 and Ligia Toro1,2,4

1 Department of Anaesthesiology, Division of Molecular Medicine
2 Department of Molecular and Medical Pharmacology
3 Department of Physiology
4 Brain Research Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90095-1778, USA

Large-conductance, voltage- and Ca2+-activated K+ channels (MaxiK, BK) are key regulators of vascular tone. Vascular MaxiK are formed by the pore-forming {alpha} subunit and the modulatory ß1 subunit, which imprints unique kinetics, Ca2+/voltage sensitivities and pharmacology to the channel. As age progresses, {alpha} subunit functional expression and protein levels diminish in coronary myocytes. However, whether ageing modifies ß1 subunit expression or the mechanism of {alpha} subunit reduction is unknown. Thus, we examined functional and pharmacological characteristics of MaxiK, as well as {alpha} and ß1 transcript levels in coronary myocytes from young and old F344 rats. The mechanism of age-dependent {alpha} subunit protein reduction involves its transcript downregulation. A corresponding loss of ß1 transcripts was also detected in old myocytes, suggesting a proportional age-dependent decrease of ß1 to {alpha} subunit protein. Indeed, MaxiK channel properties, defined by coassembly of ß1 and {alpha} subunits, were equivalent in young versus old, for example in terms of (i) activation kinetics, (ii) sensitivity to Ca2+ levels > 1 µM (iii) dehydrosoyasaponin-I-induced activation, and (iv) iberiotoxin blockade. Consistent with less MaxiK expression/function in older myocytes, the ability of iberiotoxin to contract coronary rings was reduced ~50% with ageing confirming our previous findings. 5-Hydroxytryptamine (5-HT) contractile efficacy was reduced by iberiotoxin pretreatment in young > old coronary arteries (explained by larger iberiotoxin-induced contraction and decreased dynamic range for 5-HT contraction in young versus old) with no apparent differences in nitroglycerine-induced relaxation. We propose that the age-related MaxiK reduction involves a parallel decrease of {alpha} and ß1 functional expression via a transcript downregulatory mechanism; a major impact on basal and possibly stimulated coronary contraction may contribute to altered coronary flow regulation and coronary morbidity in the elderly.

(Received 24 May 2004; accepted after revision 16 July 2004; first published online 22 July 2004)
Corresponding author L. Toro: Division of Molecular Medicine, Department of Anaesthesiology, David Geffen School of Medicine at UCLA, BH-509A CHS, Box 957115, Los Angeles, CA 90095-7115, USA. Email: ltoro{at}ucla.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. E. Werner, A. L. Meredith, R. W. Aldrich, and M. T. Nelson
Hypercontractility and impaired sildenafil relaxations in the BKCa channel deletion model of erectile dysfunction
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R181 - R188.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Cogolludo, G. Frazziano, A. M. Briones, L. Cobeno, L. Moreno, F. Lodi, M. Salaices, J. Tamargo, and F. Perez-Vizcaino
The dietary flavonoid quercetin activates BKCa currents in coronary arteries via production of H2O2. Role in vasodilatation
Cardiovasc Res, January 15, 2007; 73(2): 424 - 431.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
J. Ledoux, M. E. Werner, J. E. Brayden, and M. T. Nelson
Calcium-Activated Potassium Channels and the Regulation of Vascular Tone
Physiology, February 1, 2006; 21(1): 69 - 78.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. Lu, A. Alioua, Y. Kumar, M. Eghbali, E. Stefani, and L. Toro
MaxiK channel partners: physiological impact
J. Physiol., January 1, 2006; 570(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Senti, J. M. Fernandez-Fernandez, M. Tomas, E. Vazquez, R. Elosua, J. Marrugat, and M. A. Valverde
Protective Effect of the KCNMB1 E65K Genetic Polymorphism Against Diastolic Hypertension in Aging Women and Its Relevance to Cardiovascular Risk
Circ. Res., December 9, 2005; 97(12): 1360 - 1365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. I. Zakharov, J. P. Morrow, G. Liu, L. Yang, and S. O. Marx
Activation of the BK (SLO1) Potassium Channel by Mallotoxin
J. Biol. Chem., September 2, 2005; 280(35): 30882 - 30887.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. E. Werner, P. Zvara, A. L. Meredith, R. W. Aldrich, and M. T. Nelson
Erectile dysfunction in mice lacking the large-conductance calcium-activated potassium (BK) channel
J. Physiol., September 1, 2005; 567(2): 545 - 556.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 The Physiological Society.